Cargando…

Analysis of SOD2 rs4880 Genetic Variant in Patients with Alzheimer’s Disease

A few gene loci that contribute to Alzheimer’s Disease (AD) onset have been identified. Few studies have been published about the relationship between SOD2 rs4880 single nucleotide variant and AD, revealing inconsistent results. Therefore, the aim of the current study is to further examine the role...

Descripción completa

Detalles Bibliográficos
Autores principales: Siokas, Vasileios, Stamati, Polyxeni, Pateraki, Georgia, Liampas, Ioannis, Aloizou, Athina-Maria, Tsirelis, Daniil, Nousia, Anastasia, Sgantzos, Markos, Nasios, Grigorios, Bogdanos, Dimitrios P., Dardiotis, Efthimios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600469/
https://www.ncbi.nlm.nih.gov/pubmed/36286017
http://dx.doi.org/10.3390/cimb44100302
_version_ 1784816850271469568
author Siokas, Vasileios
Stamati, Polyxeni
Pateraki, Georgia
Liampas, Ioannis
Aloizou, Athina-Maria
Tsirelis, Daniil
Nousia, Anastasia
Sgantzos, Markos
Nasios, Grigorios
Bogdanos, Dimitrios P.
Dardiotis, Efthimios
author_facet Siokas, Vasileios
Stamati, Polyxeni
Pateraki, Georgia
Liampas, Ioannis
Aloizou, Athina-Maria
Tsirelis, Daniil
Nousia, Anastasia
Sgantzos, Markos
Nasios, Grigorios
Bogdanos, Dimitrios P.
Dardiotis, Efthimios
author_sort Siokas, Vasileios
collection PubMed
description A few gene loci that contribute to Alzheimer’s Disease (AD) onset have been identified. Few studies have been published about the relationship between SOD2 rs4880 single nucleotide variant and AD, revealing inconsistent results. Therefore, the aim of the current study is to further examine the role of the SOD2 rs4880 in AD. We performed a case-control study with a total of 641 subjects (320 patients with probable AD, and 321 healthy controls). The statistical analysis was performed assuming five genetic models. The threshold for statistical significance was set at 0.05. The results revealed no association between SOD2 rs4880 and AD in any of the assumed genetic models that were examined [log-additive OR = 0.95 (0.76–1.19), over-dominant OR = 1.15 (0.85–1.57), recessive OR = 0.85 (0.59–1.22), dominant OR = 1.03 (0.72–1.47), and co-dominant OR1 = 1.10 (0.75–1.60) and OR2 = 0.90 (0.58–1.40)]. Adjustment for sex and subgroup analyses based on sex did not reveal any statistically significant results either. Based on our findings, SOD2 rs4880 does not appear to play a determining role in the risk of developing AD. Larger studies are warranted to elucidate the connection between rs4880 and AD.
format Online
Article
Text
id pubmed-9600469
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96004692022-10-27 Analysis of SOD2 rs4880 Genetic Variant in Patients with Alzheimer’s Disease Siokas, Vasileios Stamati, Polyxeni Pateraki, Georgia Liampas, Ioannis Aloizou, Athina-Maria Tsirelis, Daniil Nousia, Anastasia Sgantzos, Markos Nasios, Grigorios Bogdanos, Dimitrios P. Dardiotis, Efthimios Curr Issues Mol Biol Article A few gene loci that contribute to Alzheimer’s Disease (AD) onset have been identified. Few studies have been published about the relationship between SOD2 rs4880 single nucleotide variant and AD, revealing inconsistent results. Therefore, the aim of the current study is to further examine the role of the SOD2 rs4880 in AD. We performed a case-control study with a total of 641 subjects (320 patients with probable AD, and 321 healthy controls). The statistical analysis was performed assuming five genetic models. The threshold for statistical significance was set at 0.05. The results revealed no association between SOD2 rs4880 and AD in any of the assumed genetic models that were examined [log-additive OR = 0.95 (0.76–1.19), over-dominant OR = 1.15 (0.85–1.57), recessive OR = 0.85 (0.59–1.22), dominant OR = 1.03 (0.72–1.47), and co-dominant OR1 = 1.10 (0.75–1.60) and OR2 = 0.90 (0.58–1.40)]. Adjustment for sex and subgroup analyses based on sex did not reveal any statistically significant results either. Based on our findings, SOD2 rs4880 does not appear to play a determining role in the risk of developing AD. Larger studies are warranted to elucidate the connection between rs4880 and AD. MDPI 2022-09-21 /pmc/articles/PMC9600469/ /pubmed/36286017 http://dx.doi.org/10.3390/cimb44100302 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Siokas, Vasileios
Stamati, Polyxeni
Pateraki, Georgia
Liampas, Ioannis
Aloizou, Athina-Maria
Tsirelis, Daniil
Nousia, Anastasia
Sgantzos, Markos
Nasios, Grigorios
Bogdanos, Dimitrios P.
Dardiotis, Efthimios
Analysis of SOD2 rs4880 Genetic Variant in Patients with Alzheimer’s Disease
title Analysis of SOD2 rs4880 Genetic Variant in Patients with Alzheimer’s Disease
title_full Analysis of SOD2 rs4880 Genetic Variant in Patients with Alzheimer’s Disease
title_fullStr Analysis of SOD2 rs4880 Genetic Variant in Patients with Alzheimer’s Disease
title_full_unstemmed Analysis of SOD2 rs4880 Genetic Variant in Patients with Alzheimer’s Disease
title_short Analysis of SOD2 rs4880 Genetic Variant in Patients with Alzheimer’s Disease
title_sort analysis of sod2 rs4880 genetic variant in patients with alzheimer’s disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600469/
https://www.ncbi.nlm.nih.gov/pubmed/36286017
http://dx.doi.org/10.3390/cimb44100302
work_keys_str_mv AT siokasvasileios analysisofsod2rs4880geneticvariantinpatientswithalzheimersdisease
AT stamatipolyxeni analysisofsod2rs4880geneticvariantinpatientswithalzheimersdisease
AT paterakigeorgia analysisofsod2rs4880geneticvariantinpatientswithalzheimersdisease
AT liampasioannis analysisofsod2rs4880geneticvariantinpatientswithalzheimersdisease
AT aloizouathinamaria analysisofsod2rs4880geneticvariantinpatientswithalzheimersdisease
AT tsirelisdaniil analysisofsod2rs4880geneticvariantinpatientswithalzheimersdisease
AT nousiaanastasia analysisofsod2rs4880geneticvariantinpatientswithalzheimersdisease
AT sgantzosmarkos analysisofsod2rs4880geneticvariantinpatientswithalzheimersdisease
AT nasiosgrigorios analysisofsod2rs4880geneticvariantinpatientswithalzheimersdisease
AT bogdanosdimitriosp analysisofsod2rs4880geneticvariantinpatientswithalzheimersdisease
AT dardiotisefthimios analysisofsod2rs4880geneticvariantinpatientswithalzheimersdisease